Lönnerdal B
Department of Nutrition, Davis 95616, USA.
Adv Exp Med Biol. 1994;357:171-5. doi: 10.1007/978-1-4615-2548-6_16.
Lactoferrin from milk may have a physiological effect on the neonate by stimulating iron acquisition and/or mucosal growth. We have hypothesized that in order to achieve such an effect(s), lactoferrin will bind to a specific receptor located on the mucosal surface of the enterocyte. We have studied the presence of lactoferrin receptors in the brush border membrane from infant rhesus monkey intestine and from fetal and infant human intestine. The receptor exhibits saturation kinetics and the binding is specific for human and monkey lactoferrin--bovine lactoferrin or human transferrin do not bind to the receptor or compete with the binding of the primate lactoferrins. Enzymatic deglycosylation does not affect the binding of human lactoferrin to its receptor, suggesting that the glycan(s) is not needed for receptor recognition. Competitive binding experiments showed that holo-lactoferrin was more effective than less Fe-saturated forms of lactoferrin with regard to receptor binding. Mn-lactoferrin bound to the receptor, while we were unable to prepare Zn-lactoferrin in any physiological buffer. The human lactoferrin receptor was isolated and found to have a MW of approximately 110 kDa. This receptor has now been cloned and is being sequenced.
牛奶中的乳铁蛋白可能通过刺激铁的摄取和/或黏膜生长对新生儿产生生理作用。我们推测,为了实现这种作用,乳铁蛋白会与位于肠上皮细胞黏膜表面的特定受体结合。我们研究了恒河猴幼猴肠道以及胎儿和婴儿人类肠道的刷状缘膜中乳铁蛋白受体的存在情况。该受体呈现饱和动力学,并且这种结合对人类和猴乳铁蛋白具有特异性——牛乳铁蛋白或人类转铁蛋白不与该受体结合,也不与灵长类乳铁蛋白的结合竞争。酶促去糖基化并不影响人乳铁蛋白与其受体的结合,这表明聚糖对于受体识别并非必需。竞争性结合实验表明,就受体结合而言,全乳铁蛋白比铁饱和度较低的乳铁蛋白形式更有效。锰乳铁蛋白与受体结合,而我们无法在任何生理缓冲液中制备锌乳铁蛋白。人乳铁蛋白受体已被分离出来,发现其分子量约为110 kDa。该受体现已被克隆并正在进行测序。